Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Slayback Garners $50m Investment From Everstone
Backing For Complex Generics Firm Follows KKR’s $60m In 2016
Jan 07 2020
•
By
David Wallace
Everstone has agreed to invest up to $50m in Slayback • Source: Shutterstock
More from Deals
More from Business